Effects of interactions between intestinal microbiota and intestinal macrophages on health

Anticancer Research

Volumn 33, Issue 7, 2013, Pages 2849-2854

  Nakata, Kazue ^a   Yamamoto, Mai ^a   Inagawa, Hiroyuki ^b   Soma, Gen Ichiro ^b,c  

^a OKAYAMA PREFECTURAL UNIVERSITY   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

^c TOKUSHIMA BUNRI UNIVERSITY   (Japan)

Author keywords

Disease; Health; Homeostasis; Intestinal macrophage; Intestinal microbiota; Review

Indexed keywords

COLONY STIMULATING FACTOR 1; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 23; INTERLEUKIN 6; PROBIOTIC AGENT; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

BACTERICIDAL ACTIVITY; BIFIDOBACTERIUM; CONFERENCE PAPER; CROHN DISEASE; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; ENTERITIS; HEALTH; HOMEOSTASIS; HUMAN; INNATE IMMUNITY; INTESTINAL MACROPHAGE; INTESTINE FLORA; LACTOBACILLUS; MACROPHAGE; MACROPHAGE FUNCTION; MALIGNANT NEOPLASTIC DISEASE; METABOLIC SYNDROME X; NONHUMAN; OBESITY; PHAGOCYTOSIS; PRIORITY JOURNAL; TH1 TH2 BALANCE; THERAPY EFFECT; ULCERATIVE COLITIS;

DISEASE; HEALTH; HOMEOSTASIS; INTESTINAL MACROPHAGE; INTESTINAL MICROBIOTA; REVIEW;

ANIMALS; HUMANS; IMMUNITY, INNATE; INFLAMMATORY BOWEL DISEASES; INTESTINES; MACROPHAGES; METABOLIC SYNDROME X; METAGENOME; NEOPLASMS;

EID: 84883292453     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (49)

1. Stefater JA 3rd, Ren S, Lang RA and Duffield JS: Metchnikoff's policemen: Macrophages in development, homeostasis and regeneration. Trends Mol Med 17: 743-752, 2011.
2. Galli SJ, Borregaard N and Wynn TA: Phenotypic and functional plasticity of cells of innate immunity: Macrophages, mast cells and neutrophils. Nat Immunol 12: 1035-1044, 2011.
3. Kohchi C, Inagawa H, Hino, M, Oda M, Nakata K, Yoshida A, Hori H, Terada H, Makino K, Takiguchi K and Soma G.-I: Utilization of macrophages in anticancer therapy: The macrophage network theory. Anticancer Res 24: 3311-3320, 2004.
4. Smythies LE, Sellers M, Clements RH, Mosteller-barnum M, Meng G, Benjamin WH, Orenstein JM and Smith PD: Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity. J Clin Invest 115: 66-75, 2005.
5. Smith PD, Smythies LE, Shen R, Greenwell-Wild T, Gliozzi M and Wahl SM: Intestinal macrophages and response to microbial encroachment. Mucosal Immunol 4: 31-42, 2011.
6. Mowat AM and Bain CC: Mucosal macrophages in intestinal homeostasis and inflammation. J Innate Immun 3: 550-564, 2011.
7. Balish E and Warner T: Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. Am J Pathol 160: 2253-2257, 2002.
8. Sellon RK, Tonkonogy S, Schultz M, Dieleman LA, Grenther W, Balish E, Rennick DM and Sartor RB: Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 66: 5224-5231, 1998.
9. Matsumoto S, Hara T, Hori T, Mitsuyama K, Nagaoka M, Tomiyasu N, Suzuki A and Sata M: Probiotic Lactobacillusinduced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of proinflammatory cytokines in lamina propria mononuclear cells. Clin Exp Immunol 140: 417-426, 2005.
10. Kamada N, Hisamatsu T, Okamoto S, Sato T, Matsuoka K, Arai K, Nakai T, Hasegawa A, Inoue N, Watanabe N, Akagawa KS and Hibi T: Abnormally differentiated subsets of intestinal macrophage play a key role in Th1-dominant chronic colitis through excess production of IL-12 and IL-23 in response to bacteria. J Immunol 175: 6900-6908, 2005.
11. Verreck FA, de Boer T, Langenberg DM, Hoeve MA, Kramer M, Vaisberg E, Kastelein R, Kolk A, de Waal-Malefyt R and Ottenhoff TH: Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci USA 101: 4560-4565, 2004.
12. Sierra-Filardi E, Puig-Kroger A, Blanco FJ, Nieto C, Bragado R, Palomero MI, Bernabeu C, Vega MA and Corbi AL: Activin A skews macrophage polarization by promoting a proinflammatory phenotype and inhibiting the acquisition of anti-inflammatory macrophage markers. Blood 117: 5092-5101, 2011.
13. Nakata K, Inagawa H, Nishizawa T, Kohchi C and Soma GI: Specific messenger RNA expression for signal transduction molecules by lipopolysaccharide in intestinal macrophages. Clin Exp Immunol 143: 484-493, 2006.
14. Yoshioka N, Taniguchi Y, Yoshida A, Nakata K, Nishizawa T, Inagawa H, Kohchi C and Soma G: Intracellular localization of CD14 protein in intestinal macrophages. Anticancer Res 29: 865-869, 2009.
15. Nakata K, Inagawa H, Nishizawa T, Honda T, Kohchi C, Tonomoto Y, Yoshimura H, Nagasue N, Natori S, Terada H and Soma G: Inherent potential for production of tumor necrosis factor-alpha by human intestinal macrophages. Int J Colorectal Dis 21: 339-347, 2006.
16. Hotamisligil GS, Arner P, Caro JF, Atkinson RL and Spiegelman BM: Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95: 2409-2415, 1995.
17. Neels JG and Olefsky JM: Inflamed fat: What starts the fire? J Clin Invest 116: 33-35, 2006.
18. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H and Flier JS: TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 116: 3015-3025, 2006.
19. Akashi S, Shimazu R, Ogata H, Nagai Y, Takeda K, Kimoto M and Miyake K: Cutting edge: Cell surface expression and lipopolysaccharide signaling via the toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages. J Immunol 164: 3471-3475, 2000.
20. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, Neyrinck AM, Fava F, Tuohy KM, Chabo C, Waget A, Delmee E, Cousin B, Sulpice T, Chamontin B, Ferrieres J, Tanti JF, Gibson GR, Casteilla L, Delzenne NM, Alessi MC and Burcelin R: Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56: 1761-1772, 2007.
21. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM and Burcelin R: Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes 57: 1470-1481, 2008.
22. Ghoshal S, Witta J, Zhong J, de Villiers W and Eckhardt E: Chylomicrons promote intestinal absorption of lipopolysaccharides. J Lipid Res 50: 90-97, 2009.
23. Kesse E, Clavel-Chapelon F and Boutron-Ruault MC: Dietary patterns and risk of colorectal tumors: A cohort of French women of the National Education System (E3N). Am J Epidemiol 164: 1085-1093, 2006.
24. Yusof AS, Isa ZM and Shah SA: Dietary patterns and risk of colorectal cancer: A systematic review of cohort studies (2000-2011). Asian Pac J Cancer Prev 13: 4713-4717, 2012.
25. Greer JB and O'Keefe SJ: Microbial induction of immunity, inflammation, and cancer. Front Physiol 1: 1-8 2011.
26. Ridlon JM, Kang DJ and Hylemon PB: Bile salt biotransformations by human intestinal bacteria. J Lipid Res 47: 241-259, 2006.
27. Erdman SE, Rao VP, Poutahidis T, Rogers AB, Taylor CL, Jackson EA, Ge Z, Lee CW, Schauer DB, Wogan GN, Tannenbaum SR and Fox JG: Nitric oxide and TNF-α trigger colonic inflammation and carcinogenesis in Helicobacter hepaticus-infected, Rag2-deficient mice. Proc Natl Acad Sci USA 106: 1027-1032, 2009.
28. Cryan JF and O'Mahony SM: The microbiome-gut-brain axis: From bowel to behavior. Neurogastroenterol Motil 23: 187-192, 2011.
29. Forsythe P, Sudo N, Dinan T, Taylor VH and Bienenstock J: Mood and gut feelings. Brain Behav Immun 24: 9-16, 2010.
30. Diaz Heijtz R, Wang S, Anuar F, Qian Y, Bjorkholm B, Samuelsson A, Hibberd ML, Forssberg H and Pettersson S: Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci USA 108: 3047-3052, 2011.
31. Rhee SH, Pothoulakis C and Mayer EA: Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol 6: 306-314, 2009.
32. Sudo N, Chida Y, Aiba Y, Sonoda J, Oyama N, Yu XN, Kubo C and Koga Y: Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol 558: 263-275, 2004.
33. Neufeld KM, Kang N, Bienenstock J and Foster JA: Reduced anxiety-like behavior and central neurochemical change in germfree mice. Neurogastroenterol Motil 23: 255-e119, 2011.
34. Lyte M, Li W, Opitz N, Gaykema RP and Goehler LE: Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium. Physiol Behav 89: 350-357, 2006.
35. Asano Y, Hiramoto T, Nishino R, Aiba Y, Kimura T, Yoshihara K, Koga Y and Sudo N: Critical role of gut microbiota in the production of biologically active, free catecholamines in the gut lumen of mice. Am J Physiol Gastrointest Liver Physiol 303: G1288-1295, 2012.
36. Vlisidou I, Lyte M, van Diemen PM, Hawes P, Monaghan P, Wallis TS and Stevens MP: The neuroendocrine stress hormone norepinephrine augments Escherichia coli O157:H7-induced enteritis and adherence in a bovine ligated ileal loop model of infection. Infect Immun 72: 5446-5451, 2004.
37. Goehler LE, Gaykema RP, Opitz N, Reddaway R, Badr N and Lyte M: Activation in vagal afferents and central autonomic pathways: early responses to intestinal infection with Campylobacter jejuni. Brain Behav Immun 19: 334-344, 2005.
38. Lundin A, Bok CM, Aronsson L, Bjorkholm B, Gustafsson JA, Pott S, Arulampalam V, Hibberd M, Rafter J and Pettersson S: Gut flora, Toll-like receptors and nuclear receptors: A tripartite communication that tunes innate immunity in large intestine. Cell Microbiol 10: 1093-1103, 2008.
39. Papoff P, Ceccarelli G, d'Ettorre G, Cerasaro C, Caresta E, Midulla F and Moretti C: Gut microbial translocation in critically ill children and effects of supplementation with preand pro biotics. Int J Microbiol 2012: 151393, 2012.
40. Lukjancenko O, Ussery DW and Wassenaar TM: Comparative genomics of Bifidobacterium, Lactobacillus and related probiotic genera. Microb Ecol 63: 651-673, 2012.
41. Reid G, Jass J, Sebulsky MT and McCormick JK: Potential uses of probiotics in clinical practice. Clin Microbiol Rev 16: 658-672, 2003.
42. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG and de Vries JE: Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 174: 1209-1220, 1991.
43. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE and Roncarolo MG: A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389: 737-742, 1997.
44. vett SH, O'Hearn DJ, Li X, Huang SK, Finkelman FD and Wills-Karp M: Interleukin-12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice. J Exp Med 182: 1527-1536, 1995.
45. Asadullah K, Sterry W and Volk HD: Interleukin-10 therapyreview of a new approach. Pharmacol Rev 55: 241-269, 2003.
46. Trinchieri G: Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol 3: 133-146, 2003.
47. Kaji R, Kiyoshima-Shibata J, Nagaoka M, Nanno M and Shida K: Bacterial teichoic acids reverse predominant IL-12 production induced by certain lactobacillus strains into predominant IL-10 production via TLR2-dependent ERK activation in macrophages. J Immunol 184: 3505-3513, 2010.
48. Ichikawa S, Miyake M, Fujii R and Konishi Y: MyD88- associated ROS generation is crucial for Lactobacillus induced IL-12 production in macrophage. PLoS One 7: e35880, 2012.
49. Platt AM, Bain CC, Bordon Y, Sester DP and Mowat AM: An independent subset of TLR expressing CCR2-dependent macrophages promotes colonic inflammation. J Immunol 184: 6843-6854, 2010.